thehill.com
Here is the basics. Bond yield has an inverse relationship with price. How much it moves depends on the duration of the bond. I wouldn’t have bought a mall REIT bond Because o the credit risk. You should also consider tax implications when buying bonds. QDI offers better tax treatment than ordinary interest.
Can you trade individual bonds or do you have to hold to maturity? Does that include treasuries?
You can trade bonds on rates and credit. Tsy is the best for rates because of liquidity. Bid/ask spread is wide if you are buying odd lots.
Very much describes my NRG position.
Great example of the benefit of adding when the opportunity arises. Well done!
I actually added on the way up, but then added more when it was back down as well.
PLTR is a long term hold. I would not sell the stock, but sell upside calls at resistance levels. $18 is a resistance level and I would sell calls against that levels. When it breaks through that level, then sell call at the next resistance level.Big beat for PLTR. With this quarter in the books, PLTR now qualifies for the S&P 500.
Earnings are crushing it. From FS Insights:
Good plan, thanks! The future addition to the S&P 500 will be a big catalyst for PLTR. On my watchlist now. Looking to start a position.
Quick question, are you buying brokerage CDs via your E-Trade account? How much does the price/value of a CD change with changing interest rates? I read if you want to get out of a brokerage CD you have to sell it on the secondary market. Unlike a bank CD where you just pay a small penalty (i.e., few months of interest).
Not sure, hoping to see price changes reflect changes in rates.
Damn straight:
Lots of tubby people out there that need these medications. Huge market (pun intended).Nice pop for LLY off the approval for obesity. Thought NVO might get hit a little from the added competition but doesn’t look like it. Demand might be strong enough for both of them for now.
FDA approves Eli Lilly's tirzepatide for weight loss, paving way for wider use of blockbuster drug
The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry.www.cnbc.com
Did MCD pop, too? LOL....Nice pop for LLY off the approval for obesity. Thought NVO might get hit a little from the added competition but doesn’t look like it. Demand might be strong enough for both of them for now.
FDA approves Eli Lilly's tirzepatide for weight loss, paving way for wider use of blockbuster drug
The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry.
Sounds like DTC in 2025. It’s again held that firm 80s support.Disney expands cost-cutting plan by $2 billion, posts better-than-expected profit
Investors are looking for updates on Disney CEO Bob Iger's strategy for the slumping media giant.
So far the market is reacting well to the report, but it does have plenty of bad along with the good. Also, I assume the strike will impact Q4.Disney expands cost-cutting plan by $2 billion, posts better-than-expected profit
Investors are looking for updates on Disney CEO Bob Iger's strategy for the slumping media giant.
That about 10% to where it’s trading after hours currently, that’s pretty good imo.
Iger said strikes will have minimal impact in the near term, it's getting the movies ready for the summer season that he said could be an issue.
FYI - I read a few negative analyses of the RIVN earnings report. The burn rate is still way too high at $1.5B or so. Cash on hand is $9.3B and the money only gets them to late 2025. More raising?
